Kousuke Noda

Author PubWeight™ 66.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006 2.37
2 Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol 2013 2.17
3 Correlation between decreased choroidal blood flow velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol 2013 1.72
4 Characterization of cytokine responses to retinal detachment in rats. Mol Vis 2006 1.43
5 Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci 2009 1.25
6 (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes 2009 1.24
7 Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci 2008 1.21
8 Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008 1.19
9 Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J 2009 1.18
10 Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 2005 1.18
11 Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 2007 1.17
12 Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol 2007 1.16
13 Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 2006 1.14
14 Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol 2006 1.12
15 HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest 2008 1.11
16 Expression of vascular endothelial growth factor in eyes with Coats' disease. Invest Ophthalmol Vis Sci 2013 1.09
17 Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol 2008 1.07
18 Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci 2011 1.06
19 In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J 2008 1.06
20 Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci 2011 1.04
21 Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci 2007 1.00
22 von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 2010 0.99
23 Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci 2008 0.98
24 Intraoperative breakage of a 25-gauge vitreous cutter. Am J Ophthalmol 2004 0.95
25 Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Lab Invest 2012 0.95
26 Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol Vis 2011 0.94
27 (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol 2008 0.93
28 Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection. Jpn J Ophthalmol 2009 0.93
29 Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation. Am J Pathol 2010 0.92
30 Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 2005 0.92
31 Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol 2014 0.92
32 Retinal phototoxicity in a novel murine model of intraocular lens implantation. Mol Vis 2009 0.92
33 Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2005 0.91
34 Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci 2009 0.91
35 Retinal ganglion cell loss in superoxide dismutase 1 deficiency. Invest Ophthalmol Vis Sci 2011 0.91
36 VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. Am J Pathol 2011 0.90
37 Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis 2012 0.90
38 Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization. Am J Pathol 2009 0.88
39 Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina 2013 0.88
40 Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy. Jpn J Ophthalmol 2015 0.87
41 Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis. FASEB J 2008 0.86
42 Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp Eye Res 2009 0.86
43 Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol 2014 0.86
44 Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis 2012 0.85
45 The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization. Am J Pathol 2012 0.84
46 Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2008 0.84
47 Retinal outer layer thickness increases with regression of multiple evanescent white dot syndrome and visual improvement positively correlates with photoreceptor outer segment length. Acta Ophthalmol 2014 0.84
48 Retinal outer layer thickness increases after vitrectomy for epiretinal membrane, and visual improvement positively correlates with photoreceptor outer segment length. Graefes Arch Clin Exp Ophthalmol 2013 0.84
49 Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina 2012 0.82
50 Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2012 0.82
51 Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Invest Ophthalmol Vis Sci 2007 0.82
52 Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci 2013 0.81
53 Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. Mol Vis 2010 0.81
54 Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm 2014 0.80
55 Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor. J Neuroinflammation 2011 0.80
56 Replication of a microsatellite genome-wide association study of Behcet's disease in a Korean population. Rheumatology (Oxford) 2012 0.80
57 Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation. Br J Ophthalmol 2006 0.80
58 Tissue factor expression in human pterygium. Mol Vis 2011 0.80
59 Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res 2012 0.80
60 Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 2013 0.79
61 Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis 2013 0.79
62 Expression of αB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res 2013 0.79
63 Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol 2012 0.79
64 Aqueous humour levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol 2013 0.78
65 Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes. J Diabetes Complications 2012 0.78
66 Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci 2013 0.78
67 A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of wormlike, wavy tangles of filaments. Graefes Arch Clin Exp Ophthalmol 2004 0.78
68 Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol 2012 0.77
69 Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand 2007 0.77
70 Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Mol Vis 2012 0.76
71 A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol 2013 0.75
72 Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 2013 0.75
73 Membrane tissue on the optic disc may cause macular schisis associated with a glaucomatous optic disc without optic disc pits. Clin Ophthalmol 2013 0.75
74 A comparison of N-glycan profiles in human plasma and vitreous fluid. Graefes Arch Clin Exp Ophthalmol 2014 0.75
75 [Etiology of diabetic retinopathy]. Nihon Rinsho 2016 0.75
76 New retractor capable of aspirating fluids during scleral buckling surgery. Retina 2009 0.75
77 Repair of blowout orbital floor fracture by periosteal suturing. Clin Experiment Ophthalmol 2010 0.75
78 Secondary macular hole formation with presumed evulsion of foveal hard exudates in a patient with diabetic retinopathy. Jpn J Ophthalmol 2010 0.75
79 Treatment of retinal detachment after macular translocation with scleral infolding: preservation of macular translocation. Retina 2004 0.75
80 Intraoperative dehiscence of laser subepithelial keratomileusis (LASEK) flap during retinal detachment surgery. Acta Ophthalmol Scand 2007 0.75
81 Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy. Acta Ophthalmol 2013 0.75
82 Increased vascular endothelial growth factor level in the subretinal fluid of eye with vasoproliferative retinal tumors. Retin Cases Brief Rep 2015 0.75
83 Pars plana vitrectomy for macular schisis associated with peripapillary intrachoroidal cavitation. Ophthalmic Surg Lasers Imaging Retina 2014 0.75
84 [Effects of carteolol hydrochloride on experimental choroidal neovascularization]. Nippon Ganka Gakkai Zasshi 2011 0.75